|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 18724892.7 (espacenet) (Federated) (European Patent Register), 20180516 | Patent/reg. no. and date | DK/EP 3709996, 20240228 | Publication date | 20200923 | Priority no. and date | WO PCT/EP2017/079506, 20171116 | EP pub. no. and date |
EP 3709996 20200923 | Effective date | | Applicant/owner | The Institute of Cancer Research: Royal Cancer Hospital, 123 Old Brompton Road
London SW7 3RP, GB, The Royal Marsden NHS Foundation Trust, Fulham Road
London SW3 6JJ, GB | Applicant ref. no. | V473135DK00 | Inventor | BANERJI, Udai, c/o The Institute of Cancer Research: Royal Cancer Hospital 123 Old Brompton Road
London SW7 3RP, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/37 (2006.01) , A61K 31/573 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | Title | Coumarin-derivat til behandling eller forebyggelse af en celleproliferativ lidelse | Int. application no. | EP2018062805 | Int. publication no. | WO2019096449 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |